BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gampe C, Verma VA. Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients. J Med Chem 2020;63:14357-81. [DOI: 10.1021/acs.jmedchem.0c01177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Shen J, Jiang X, Wu H, Xu J, Zhu Q, Zhang P. Copper-catalyzed selective oxidation of hydrazones through C(sp3)-H functionalization. Org Biomol Chem 2021;19:8917-23. [PMID: 34617555 DOI: 10.1039/d1ob01563j] [Reference Citation Analysis]
2 Serafini M, Cargnin S, Massarotti A, Tron GC, Pirali T, Genazzani AA. What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications. J Med Chem 2021;64:4410-29. [PMID: 33847110 DOI: 10.1021/acs.jmedchem.1c00181] [Reference Citation Analysis]
3 Zhang Z, Wang Y, Chen X, Song X, Tu Z, Chen Y, Zhang Z, Ding K. Characterization of an aromatic trifluoromethyl ketone as a new warhead for covalently reversible kinase inhibitor design. Bioorg Med Chem 2021;50:116457. [PMID: 34670167 DOI: 10.1016/j.bmc.2021.116457] [Reference Citation Analysis]
4 Chamakuri S, Lu S, Ucisik MN, Bohren KM, Chen YC, Du HC, Faver JC, Jimmidi R, Li F, Li JY, Nyshadham P, Palmer SS, Pollet J, Qin X, Ronca SE, Sankaran B, Sharma KL, Tan Z, Versteeg L, Yu Z, Matzuk MM, Palzkill T, Young DW. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proc Natl Acad Sci U S A 2021;118:e2111172118. [PMID: 34426525 DOI: 10.1073/pnas.2111172118] [Reference Citation Analysis]
5 Qiao J, Li YS, Zeng R, Liu FL, Luo RH, Huang C, Wang YF, Zhang J, Quan B, Shen C, Mao X, Liu X, Sun W, Yang W, Ni X, Wang K, Xu L, Duan ZL, Zou QC, Zhang HL, Qu W, Long YH, Li MH, Yang RC, Liu X, You J, Zhou Y, Yao R, Li WP, Liu JM, Chen P, Liu Y, Lin GF, Yang X, Zou J, Li L, Hu Y, Lu GW, Li WM, Wei YQ, Zheng YT, Lei J, Yang S. SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model. Science 2021;371:1374-8. [PMID: 33602867 DOI: 10.1126/science.abf1611] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 42.0] [Reference Citation Analysis]
6 Dampalla CS, Kim Y, Bickmeier N, Rathnayake AD, Nguyen HN, Zheng J, Kashipathy MM, Baird MA, Battaile KP, Lovell S, Perlman S, Chang KO, Groutas WC. Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease. J Med Chem 2021;64:10047-58. [PMID: 34213885 DOI: 10.1021/acs.jmedchem.1c00319] [Reference Citation Analysis]
7 Lentini NA, Schroeder CM, Harmon NM, Huang X, Schladetsch MA, Foust BJ, Poe MM, Hsiao CC, Wiemer AJ, Wiemer DF. Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol. ACS Med Chem Lett 2021;12:136-42. [PMID: 33488975 DOI: 10.1021/acsmedchemlett.0c00586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vankadara S, Dawson MD, Fong JY, Oh QY, Ang QA, Liu B, Chang HY, Koh J, Koh X, Tan QW, Joy J, Chia CSB. A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.2c00260] [Reference Citation Analysis]
9 Subbaiah MAM, Meanwell NA. Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design. J Med Chem 2021;64:14046-128. [PMID: 34591488 DOI: 10.1021/acs.jmedchem.1c01215] [Reference Citation Analysis]
10 Yang T, Cuesta A, Wan X, Craven GB, Hirakawa B, Khamphavong P, May JR, Kath JC, Lapek JD Jr, Niessen S, Burlingame AL, Carelli JD, Taunton J. Reversible lysine-targeted probes reveal residence time-based kinase selectivity. Nat Chem Biol 2022. [PMID: 35590003 DOI: 10.1038/s41589-022-01019-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Vankadara S, Wong YX, Liu B, See YY, Tan LH, Tan QW, Wang G, Karuna R, Guo X, Tan ST, Fong JY, Joy J, Chia CSB. A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors. Bioorg Med Chem Lett 2021;48:128263. [PMID: 34271072 DOI: 10.1016/j.bmcl.2021.128263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chia CSB, Xu W, Shuyi Ng P. A Patent Review on SARS Coronavirus Main Protease (3CLpro ) Inhibitors. ChemMedChem 2021. [PMID: 34651447 DOI: 10.1002/cmdc.202100576] [Reference Citation Analysis]
13 Zhu J, Li L, Drelich A, Chenna BC, Mellott DM, Taylor ZW, Tat V, Garcia CZ, Katzfuss A, Tseng CK, Meek TD. Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents. Front Chem 2022;10:867928. [DOI: 10.3389/fchem.2022.867928] [Reference Citation Analysis]
14 Liu Y, Wang L, Zhao L, Zhang Y. Structure, properties of gossypol and its derivatives-from physiological activities to drug discovery and drug design. Nat Prod Rep 2022. [PMID: 35587693 DOI: 10.1039/d1np00080b] [Reference Citation Analysis]
15 Li L, Chenna BC, Yang KS, Cole TR, Goodall ZT, Giardini M, Moghadamchargari Z, Hernandez EA, Gomez J, Calvet CM, Bernatchez JA, Mellott DM, Zhu J, Rademacher A, Thomas D, Blankenship LR, Drelich A, Laganowsky A, Tseng CK, Liu WR, Wand AJ, Cruz-Reyes J, Siqueira-Neto JL, Meek TD. Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases. J Med Chem 2021;64:11267-87. [PMID: 34288674 DOI: 10.1021/acs.jmedchem.1c00628] [Reference Citation Analysis]